Autoimmune Phenomenon Associated With Posttransplant Lymphoproliferative Disorder

Autoimmune Phenomenon Associated With Posttransplant Lymphoproliferative Disorder

Saved in:

Bibliographic Details
Main Authors:	Pierre Isnard, Tony Huynh, Ludovic Lhermitte, Olivier Hermine, Eric Thervet, Thierry Jo Molina
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024923016388
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Posttransplant Lymphoproliferative Disorders
by: Hazem A. H. Ibrahim, et al.
Published: (2012-01-01)

Isolated Upper Extremity Posttransplant Lymphoproliferative Disorder in a Child
by: Sarah E. Halula, et al.
Published: (2015-01-01)

Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders
by: Vikas R. Dharnidharka, et al.
Published: (2019-03-01)

Ophthalmoplegia and Tumor Lysis Syndrome: An Uncommon Presentation of Posttransplant Lymphoproliferative Disorder
by: Lauren M. Granat, et al.
Published: (2022-09-01)

Posttransplant Lymphoproliferative Disease after Lung Transplantation
by: Isabel P. Neuringer
Published: (2013-01-01)

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant
by: Bharat Malhotra, et al.
Published: (2015-01-01)

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate
by: Clare J. Twist, et al.
Published: (2013-01-01)

Masked Arginine Vasopressin Deficiency in a Kidney Transplant Recipient With Posttransplant Lymphoproliferative Disorder
by: Annie Liu, et al.
Published: (2024-09-01)

Posttransplant Lymphoproliferative Disease after Pediatric Solid Organ Transplantation
by: Martin Mynarek, et al.
Published: (2013-01-01)

Castleman’s Disease and Posttransplant Lymphoproliferative Disorder after Liver Transplant: 3-Year Follow-Up
by: Lokesh K. Jha, et al.
Published: (2018-01-01)

Molecular Pathogenesis of B-Cell Posttransplant Lymphoproliferative Disorder: What Do We Know So Far?
by: J. Morscio, et al.
Published: (2013-01-01)

Late-Onset Posttransplant Lymphoproliferative Disorders after Solid Organ Transplantation in Adults: A Case Series and Review of the Literature
by: S. Gandhi, et al.
Published: (2020-01-01)

Posttransplant Lymphoproliferative Disorder Presenting as Testicular Lymphoma in a Kidney Transplant Recipient: A Case Report and Review of the Literature
by: Steve Omoruyi Obanor, et al.
Published: (2018-01-01)

The Impact of Posttransplant Lymphoproliferative Disease in High-risk Kidney Transplant Recipients: Benefits of Prevention
by: Bryce A. Kiberd, MD, et al.
Published: (2025-05-01)

Feasibility and Safety of Ex Vivo Delivery of Rituximab to Lung Allografts in Transplant Recipients at High Risk for Epstein-Barr Virus–associated Posttransplant Lymphoproliferative Disorder
by: Victor H. Ferreira, PhD, et al.
Published: (2025-04-01)

HHVs AND LYMPHOPROLIFERATIVE DISORDERS
by: C Quadrelli, et al.
Published: (2011-10-01)

Waitlist Mortality and Posttransplant Outcomes in African Americans with Autoimmune Liver Diseases
by: John Paul Nsubuga, et al.
Published: (2021-01-01)

Daratumumab for refractory posttransplant autoimmune hemolytic anemia: An option beyond the obvious
by: Sreedhar Jayakrishnan Cherulil, et al.
Published: (2025-01-01)

Methotrexate-Associated Lymphoproliferative Disorder With Gingival Swelling
by: Saki Manabe, et al.
Published: (2022-10-01)

Central nervous system posttransplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation successfully treated with combination therapy of acalabrutinib and immunochemotherapy: A case report and literature review
by: Peihao Zheng, et al.
Published: (2025-02-01)

Fcγ-Receptor IIIA Polymorphism p.158F Has No Negative Predictive Impact on Rituximab Therapy with and without Sequential Chemotherapy in CD20-Positive Posttransplant Lymphoproliferative Disorder
by: Heiner Zimmermann, et al.
Published: (2014-01-01)

An Uncommon Case of Eosinophilic Myocarditis in a Patient With Autoimmune Lymphoproliferative Syndrome
by: Maria T. Gamero, et al.
Published: (2024-07-01)

Autoimmune Lymphoproliferative Syndrome: A Rare Cause of Disappearing HDL Syndrome
by: Swetha Sriram, et al.
Published: (2016-01-01)

Lymphoproliferative disorders affecting organs of the head and neck
by: F. Sh. Kamolova, et al.
Published: (2022-08-01)

Eprex in the management of anemia related to lymphoproliferative disorders
by: P. N. Barlamov, et al.
Published: (2022-11-01)

Lenalidomide in the Treatment of Lymphoproliferative Disorders and Multiple Myeloma
by: Anna Marina Liberati, et al.
Published: (2013-01-01)

Pure Red Cell Aplasia and Lymphoproliferative Disorders: An Infrequent Association
by: Efthymia Vlachaki, et al.
Published: (2012-01-01)

Posttransplant Intrarenal Lymphangiectasia
by: Ali Kord, et al.
Published: (2020-01-01)

High occurrence of autoimmune and lymphoproliferative manifestations in adults with common variable immunodeficiency in southern Taiwan
by: Chrong-Reen Wang, et al.
Published: (2024-12-01)

Wilson’s Disease with Lymphoproliferative Disorder: A Case Report
by: Ashish Jha, et al.
Published: (2025-04-01)

Autoimmune Lymphoproliferative Syndrome and Epstein-Barr Virus-Associated Lymphoma: An Adjunctive Diagnostic Role for Monitoring EBV Viremia?
by: Romina Pace, et al.
Published: (2013-01-01)

The prognostic value of posttransplant chimerism
by: A. A. Sipol, et al.
Published: (2022-11-01)

An Unusual Immediate Posttransplant Eruption
by: Ravi K. Mallavarapu, et al.
Published: (2025-02-01)

Is immune effector cell-associated enterocolitis a CAR T-cell lymphoproliferative disorder?
by: Kayra Somay, et al.
Published: (2025-07-01)

Methotrexate-Associated Lymphoproliferative Disorder Developed Ectopically in the Maxillary Gingiva and Bilateral Lungs
by: Kyoichi Obata, et al.
Published: (2020-01-01)

Clinical, laboratory, and morphological characteristics of kidney damage in lymphoproliferative disorders
by: B. T. Dzhumabaeva, et al.
Published: (2017-04-01)

Antithrombotic Therapy in Patients with Malignant Lymphoproliferative Disorders Treated with Ibrutinib
by: EI Emelina, et al.
Published: (2019-09-01)

A Rare Presentation of Isolated CNS Posttransplantation Lymphoproliferative Disorder
by: Jaime Morris, et al.
Published: (2017-01-01)

Prognostic Value of the PRAME Gene Expression in T-Cell Lymphoproliferative Disorders
by: EA Penskaya, et al.
Published: (2018-12-01)

Eculizumab in Posttransplant TMA: Unproven Benefit
by: Romy N. Bouwmeester, et al.
Published: (2024-06-01)